Applied therapeutics reports fourth quarter and year-end 2023 financial results

New york, march 06, 2024 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt) (the “company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter and full year ended december 31, 2023.
APLT Ratings Summary
APLT Quant Ranking